Medicus Pharma Ltd. Common Stock (MDCXW)
R&D Expense Growth
81.47%
Quarterly · Period ending:
MDCXW R&D Expense Growth
Latest reported81.47%period ending
Latest reported81.47%period ending
MDCXW Quarterly R&D Growth (QoQ) (0.00% → 81.47%)
Latest values, visible window
High-resolution chart · PNG
MDCXW r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 81.4711% | |
| 4.3815% | |
| -75.0931% | |
| 622.5978% | |
| -28.2447% | |
| 46.964% | |
| 75.5732% | |
| -27.2521% | |
| 237.8061% | |
| 817.1996% | |
| -14.6058% | |
| -18.5174% | |
| 0% |